Artificial intelligence influences every aspect of our lives and
creates revolutionary effects in the pharmaceutical industry as
well as in many other sectors. From DeepMind's AlphaGo success
to Tempus' personalized approaches to cancer treatment,
AI-enabled innovations offer not only scientific achievements, but
also wide-ranging advantages such as operational efficiency, cost
reduction and risk reduction. However, this technological leap also
raises critical questions about the traditional processes of the
pharmaceutical industry and the patent system.
According to data from the Tufts Drug Development Research
Center, it takes about 10 years for a drug to be developed and put
on the market, and it costs $ 2.558 billion. In particular,
clinical trials account for the majority of this cost, while the
success rate is below 10%. These challenges cause the
pharmaceutical industry to look for more sustainable and rapid
solutions.